ICAD INC (ICAD)
US44934S2068 - Common Stock
iCAD to Report First Quarter 2024 Financial Results on May 15, 2024
NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions,...
iCAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium
ProFound Cloud, powered by Google Cloud architecture and Google’s Health AI innovations, redefines accessibility to critical insights, empowering...
iCAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation
Provides a holistic breast health solution, including breast cancer screening focused on quality, safety and efficiency, breast cancer detection, breast...
iCAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting
Study confirms iCAD’s Breast Arterial Calcification AI Algorithm successfully detects calcification of breast vessels, an indicator of cardiovascular...
iCAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale
ProFound Cloud redefines accessibility to critical insights, empowering radiologists in early breast cancer detection...
Artificial Intelligence, Real Profits: 3 Stocks to Outsmart the Market
These AI stocks will get big boosts from the proliferation of AI over the longer term, but the market is not giving them enough love.
iCAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results
Annual Recurring Revenue of $8.7 million, an increase of 15% year-over-yearFull-Year Operating Cash Flow ($5) million vs. ($12.8) million prior yearYear...
The Hot List: 3 AI Stocks Worth Buying on Weakness
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.
ICAD stock jumps 11% ahead of medical meeting presentations (NASDAQ:ICAD)
ICAD (ICAD) stock jumped 11% Wednesday after the company said it was making several presentations at the European Congress of Radiology annual meeting this week. Read more here.
iCAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings
Clinical evidence demonstrates ProFound Detection’s AI may help reduce breast interval cancer (IC) rates and decrease recall rates without additional false...
iCAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)
Dr. Hricak offers extensive experience in radiology, real-world application of AI-enabled imaging solutions, research, and global healthcare perspectives...
iCAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
NASHUA, N.H., Feb. 27, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader in clinically proven AI-powered solutions that enable medical...
iCAD shares rally 15% amid GE Healthcare AI integration update (NASDAQ:ICAD)
iCAD (ICAD) shares rallied 15% on news that its AI-powered applications have been integrated into GE HealthCare's (GEHC) new MyBreastAI Suite for breast cancer detection.
iCAD’s AI-powered solutions to Help Accelerate Breast Cancer Detection in New Collaboration with GE Healthcare
Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite*AI applications streamline workflow and support...
iCAD’s ProFound AI Can Predict 1-2 Year Risk for Breast Cancer and Reveal Insights for Heart Disease
New research presented at Radiological Society of North America annual meeting confirms ability of ProFound Breast Health Suite to predict a...
Discover Future Growth Stocks: 3 Penny Stocks Poised for Massive Returns
As the Street realizes that we're in the early stages of the business cycle, penny stocks should boom. Here are three great names to buy.
iCAD to Participate in the 14th Annual Craig-Hallum Alpha Select Conference
NASHUA, N.H., Nov. 14, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by...
iCAD Reports Financial Results for Third Quarter Ended September 30, 2023
Company to host conference call and webcast today at 4:30 PM ET...
7 Biotech Stocks to Buy for Big-Time Gains
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.
iCAD to Report Third Quarter 2023 Financial Results on November 13, 2023
NASHUA, N.H., Oct. 30, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) is a global leader on a mission to create a world where cancer can’t hide by...
The 7 Most Undervalued AI Penny Stocks to Buy: October 2023
Unlock exponential growth with the next big undervalued AI penny stocks to buy, offering tremendous upside ahead.
iCAD to sell brachytherapy business line Xoft to Elekta for $5.5M (NASDAQ:ICAD)
iCAD (ICAD) on Monday said that Elekta has agreed to acquire Xoft, a subsidiary of iCAD, Inc. for approximately $5.5 million and assumed liabilities, effective immediately...
iCAD, Inc. Announces Sale of Xoft, its Brachytherapy Business Line, to Elekta
Xoft’s eBx System can now be offered to more clinics and cancer patients world-wide through Elekta’s extensive sales channels...
7 Trailblazing AI Stocks to Buy on Any Weakness
Investors are greatly underestimating the transformative power of AI at this point. Here are seven AI stocks to buy on weakness.
3 Up-and-Coming Stocks to Put on Your Must-Buy List
With many areas of technology booming and an ongoing energy revolution occurring, there are many up-and-coming stocks to buy.
Health Canada Grants Device License for iCAD's ProFound Risk 2.0, Revolutionizing Breast Cancer Risk Via a 1-2 Year Assessment
NASHUA, N.H., Aug. 16, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and...
iCAD Reports Financial Results for Second Quarter Ended June 30, 2023
Company to host conference call and webcast today at 4:30 PM ET...
5 AI Stocks That Could Turn $50,000 Into $1 Million
These five AI stocks have the power... and profits... to turn $50,000 into $1 million. Here's what you need to know before you buy.
iCAD to Report Second Quarter 2023 Financial Results on August 14, 2023
NASHUA, N.H., July 31, 2023 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and...